![](/img/cover-not-exists.png)
Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta ® in healthy subjects: A randomized, doubleâblind trial
Wynne, Chris, Schwabe, Christian, Vincent, Emmanuelle, Schueler, Armin, Ryding, Janka, Ullmann, Martin, Ghori, Vishal, Kanceva, Radmila, Stahl, MichaelVolume:
8
Journal:
Pharmacology Research & Perspectives
DOI:
10.1002/prp2.578
Date:
April, 2020
File:
PDF, 1.33 MB
2020